ID   WDR43_HUMAN             Reviewed;         677 AA.
AC   Q15061; Q15395; Q92577;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 3.
DT   28-JUN-2023, entry version 186.
DE   RecName: Full=WD repeat-containing protein 43;
DE   AltName: Full=U3 small nucleolar RNA-associated protein 5 homolog;
GN   Name=WDR43 {ECO:0000312|HGNC:HGNC:28945}; Synonyms=KIAA0007, UTP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S.,
RA   Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I. The
RT   coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of
RT   randomly sampled cDNA clones from human immature myeloid cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [2]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12429849; DOI=10.1091/mbc.e02-05-0271;
RA   Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C.,
RA   Greco A., Hochstrasser D.F., Diaz J.-J.;
RT   "Functional proteomic analysis of human nucleolus.";
RL   Mol. Biol. Cell 13:4100-4109(2002).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [5]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=17699751; DOI=10.1101/gad.436707;
RA   Prieto J.L., McStay B.;
RT   "Recruitment of factors linking transcription and processing of pre-rRNA to
RT   NOR chromatin is UBF-dependent and occurs independent of transcription in
RT   human cells.";
RL   Genes Dev. 21:2041-2054(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; THR-394; SER-399;
RP   SER-431; THR-656 AND SER-658, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; SER-431; SER-437;
RP   SER-590; THR-656 AND SER-658, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   POSSIBLE ASSOCIATION IN THE SSU PROCESSOME T-UTP SUBCOMPLEX.
RX   PubMed=22916032; DOI=10.1371/journal.pgen.1002892;
RA   Freed E.F., Prieto J.L., McCann K.L., McStay B., Baserga S.J.;
RT   "NOL11, implicated in the pathogenesis of North American Indian childhood
RT   cirrhosis, is required for pre-rRNA transcription and processing.";
RL   PLoS Genet. 8:E1002892-E1002892(2012).
RN   [11]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH UTP4 AND UTP15.
RX   PubMed=24219289; DOI=10.1139/bcb-2013-0062;
RA   Sato M., Araki N., Kumeta M., Takeyasu K., Taguchi Y., Asai T.,
RA   Furukawa K., Horigome T.;
RT   "Interaction, mobility, and phosphorylation of human orthologues of WD
RT   repeat-containing components of the yeast SSU processome t-UTP sub-
RT   complex.";
RL   Biochem. Cell Biol. 91:466-475(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-321; THR-394 AND SER-431, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-309 AND LYS-384, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-309 AND LYS-384, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [15]
RP   FUNCTION, RNA-BINDING, AND DEVELOPMENTAL STAGE.
RX   PubMed=31128943; DOI=10.1016/j.molcel.2019.05.007;
RA   Bi X., Xu Y., Li T., Li X., Li W., Shao W., Wang K., Zhan G., Wu Z.,
RA   Liu W., Lu J.Y., Wang L., Zhao J., Wu J., Na J., Li G., Li P., Shen X.;
RT   "RNA Targets Ribogenesis Factor WDR43 to Chromatin for Transcription and
RT   Pluripotency Control.";
RL   Mol. Cell 0:0-0(2019).
RN   [16] {ECO:0007744|PDB:7MQ8, ECO:0007744|PDB:7MQ9, ECO:0007744|PDB:7MQA}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.70 ANGSTROMS), FUNCTION, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=34516797; DOI=10.1126/science.abj5338;
RA   Singh S., Vanden Broeck A., Miller L., Chaker-Margot M., Klinge S.;
RT   "Nucleolar maturation of the human small subunit processome.";
RL   Science 373:eabj5338-eabj5338(2021).
CC   -!- FUNCTION: Ribosome biogenesis factor that coordinates hyperactive
CC       transcription and ribogenesis (PubMed:17699751). Part of the small
CC       subunit (SSU) processome, first precursor of the small eukaryotic
CC       ribosomal subunit. During the assembly of the SSU processome in the
CC       nucleolus, many ribosome biogenesis factors, an RNA chaperone and
CC       ribosomal proteins associate with the nascent pre-rRNA and work in
CC       concert to generate RNA folding, modifications, rearrangements and
CC       cleavage as well as targeted degradation of pre-ribosomal RNA by the
CC       RNA exosome. Involved in nucleolar processing of pre-18S ribosomal RNA.
CC       Required for optimal pre-ribosomal RNA transcription by RNA polymerase
CC       I (PubMed:17699751, PubMed:34516797). Essential for stem cell
CC       pluripotency and embryonic development. In the nucleoplasm, recruited
CC       by promoter-associated/nascent transcripts and transcription to active
CC       promoters where it facilitates releases of elongation factor P-TEFb and
CC       paused RNA polymerase II to allow transcription elongation and maintain
CC       high-level expression of its targets genes (By similarity).
CC       {ECO:0000250|UniProtKB:Q6ZQL4, ECO:0000269|PubMed:17699751,
CC       ECO:0000269|PubMed:34516797}.
CC   -!- SUBUNIT: Part of the small subunit (SSU) processome, composed of more
CC       than 70 proteins and the RNA chaperone small nucleolar RNA (snoRNA) U3
CC       (PubMed:34516797). May be a component of the proposed t-UTP subcomplex
CC       of the ribosomal small subunit (SSU) processome containing at least
CC       UTP4, WDR43, HEATR1, UTP15, WDR75 (PubMed:17699751, PubMed:22916032).
CC       Binds to RNA; binding is required for its chromatin association.
CC       Interacts with CDK9, DDX21 and SUPT6H. Interacts with RNA polymerase II
CC       (By similarity). Interacts directly with UTP4 and UTP15
CC       (PubMed:24219289). {ECO:0000250|UniProtKB:Q6ZQL4,
CC       ECO:0000269|PubMed:24219289, ECO:0000269|PubMed:34516797,
CC       ECO:0000305|PubMed:17699751, ECO:0000305|PubMed:22916032}.
CC   -!- INTERACTION:
CC       Q15061; Q969X6: UTP4; NbExp=3; IntAct=EBI-2563523, EBI-2602591;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849,
CC       ECO:0000269|PubMed:24219289, ECO:0000269|PubMed:34516797}. Nucleus,
CC       nucleolus fibrillar center {ECO:0000269|PubMed:24219289}. Nucleus,
CC       nucleoplasm {ECO:0000250|UniProtKB:Q6ZQL4}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during embryonic development, expression
CC       decreases at blastocyst stage. {ECO:0000269|PubMed:31128943}.
CC   -!- DOMAIN: N-terminal domain is required for nucleoplasm location and C-
CC       terminal domain for nucleolus location. {ECO:0000250|UniProtKB:Q6ZQL4}.
CC   -!- SIMILARITY: Belongs to the UTP5 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA05499.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA05499.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D26488; BAA05499.1; ALT_INIT; mRNA.
DR   EMBL; D87716; BAA13441.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS46251.1; -.
DR   RefSeq; NP_055946.1; NM_015131.2.
DR   PDB; 7MQ8; EM; 3.60 A; LK/LL=1-677.
DR   PDB; 7MQ9; EM; 3.87 A; LK/LL=1-677.
DR   PDB; 7MQA; EM; 2.70 A; LK/LL=1-677.
DR   PDBsum; 7MQ8; -.
DR   PDBsum; 7MQ9; -.
DR   PDBsum; 7MQA; -.
DR   AlphaFoldDB; Q15061; -.
DR   SMR; Q15061; -.
DR   BioGRID; 116772; 123.
DR   IntAct; Q15061; 22.
DR   MINT; Q15061; -.
DR   STRING; 9606.ENSP00000384302; -.
DR   GlyCosmos; Q15061; 1 site, 1 glycan.
DR   GlyGen; Q15061; 2 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; Q15061; -.
DR   PhosphoSitePlus; Q15061; -.
DR   SwissPalm; Q15061; -.
DR   BioMuta; WDR43; -.
DR   DMDM; 158518532; -.
DR   SWISS-2DPAGE; Q15061; -.
DR   EPD; Q15061; -.
DR   jPOST; Q15061; -.
DR   MassIVE; Q15061; -.
DR   MaxQB; Q15061; -.
DR   PaxDb; Q15061; -.
DR   PeptideAtlas; Q15061; -.
DR   ProteomicsDB; 60416; -.
DR   Antibodypedia; 51059; 80 antibodies from 15 providers.
DR   DNASU; 23160; -.
DR   Ensembl; ENST00000407426.8; ENSP00000384302.3; ENSG00000163811.12.
DR   GeneID; 23160; -.
DR   KEGG; hsa:23160; -.
DR   MANE-Select; ENST00000407426.8; ENSP00000384302.3; NM_015131.3; NP_055946.1.
DR   UCSC; uc002rmo.3; human.
DR   AGR; HGNC:28945; -.
DR   CTD; 23160; -.
DR   DisGeNET; 23160; -.
DR   GeneCards; WDR43; -.
DR   HGNC; HGNC:28945; WDR43.
DR   HPA; ENSG00000163811; Low tissue specificity.
DR   MIM; 616195; gene.
DR   neXtProt; NX_Q15061; -.
DR   OpenTargets; ENSG00000163811; -.
DR   PharmGKB; PA134914163; -.
DR   VEuPathDB; HostDB:ENSG00000163811; -.
DR   eggNOG; KOG4547; Eukaryota.
DR   GeneTree; ENSGT00390000004254; -.
DR   HOGENOM; CLU_020516_1_0_1; -.
DR   InParanoid; Q15061; -.
DR   OMA; KRNADNH; -.
DR   OrthoDB; 2248318at2759; -.
DR   PhylomeDB; Q15061; -.
DR   TreeFam; TF313160; -.
DR   PathwayCommons; Q15061; -.
DR   Reactome; R-HSA-6790901; rRNA modification in the nucleus and cytosol.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   SignaLink; Q15061; -.
DR   BioGRID-ORCS; 23160; 851 hits in 1165 CRISPR screens.
DR   ChiTaRS; WDR43; human.
DR   GenomeRNAi; 23160; -.
DR   Pharos; Q15061; Tbio.
DR   PRO; PR:Q15061; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q15061; protein.
DR   Bgee; ENSG00000163811; Expressed in buccal mucosa cell and 202 other tissues.
DR   ExpressionAtlas; Q15061; baseline and differential.
DR   Genevisible; Q15061; HS.
DR   GO; GO:0000785; C:chromatin; ISS:UniProtKB.
DR   GO; GO:0001650; C:fibrillar center; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR   GO; GO:0032040; C:small-subunit processome; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000993; F:RNA polymerase II complex binding; ISS:UniProtKB.
DR   GO; GO:0003711; F:transcription elongation factor activity; ISS:UniProtKB.
DR   GO; GO:0000462; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IBA:GO_Central.
DR   GO; GO:2000234; P:positive regulation of rRNA processing; IMP:UniProtKB.
DR   GO; GO:0045943; P:positive regulation of transcription by RNA polymerase I; IMP:UniProtKB.
DR   GO; GO:2000036; P:regulation of stem cell population maintenance; ISS:UniProtKB.
DR   GO; GO:0034243; P:regulation of transcription elongation by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0042274; P:ribosomal small subunit biogenesis; IDA:UniProtKB.
DR   Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 2.
DR   InterPro; IPR007148; SSU_processome_Utp12.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR44267; WD REPEAT-CONTAINING PROTEIN 43; 1.
DR   PANTHER; PTHR44267:SF1; WD REPEAT-CONTAINING PROTEIN 43; 1.
DR   Pfam; PF04003; Utp12; 1.
DR   Pfam; PF00400; WD40; 2.
DR   SMART; SM00320; WD40; 5.
DR   SUPFAM; SSF50978; WD40 repeat-like; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 1.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat; Ribosome biogenesis; RNA-binding; rRNA processing; Transcription;
KW   Transcription regulation; Ubl conjugation; WD repeat.
FT   CHAIN           1..677
FT                   /note="WD repeat-containing protein 43"
FT                   /id="PRO_0000051392"
FT   REPEAT          11..51
FT                   /note="WD 1"
FT   REPEAT          57..119
FT                   /note="WD 2"
FT   REPEAT          124..163
FT                   /note="WD 3"
FT   REPEAT          166..205
FT                   /note="WD 4"
FT   REPEAT          207..259
FT                   /note="WD 5"
FT   REPEAT          267..309
FT                   /note="WD 6"
FT   REGION          414..445
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          582..677
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        428..445
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        602..649
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        650..667
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         77
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         321
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         394
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         399
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         431
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         437
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         590
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         656
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         658
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   CROSSLNK        309
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   CROSSLNK        309
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        384
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   CROSSLNK        384
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:28112733"
SQ   SEQUENCE   677 AA;  74891 MW;  4EEAD92C30118ACD CRC64;
     MAAGGGGSCD PLAPAGVPCA FSPHSQAYFA LASTDGHLRV WETANNRLHQ EYVPSAHLSG
     TCTCLAWAPA RLQAKESPQR KKRKSEAVGM SNQTDLLALG TAVGSILLYS TVKGELHSKL
     ISGGHDNRVN CIQWHQDSGC LYSCSDDKHI VEWNVQTCKV KCKWKGDNSS VSSLCISPDG
     KMLLSAGRTI KLWVLETKEV YRHFTGHATP VSSLMFTTIR PPNESQPFDG ITGLYFLSGA
     VHDRLLNVWQ VRSENKEKSA VMSFTVTDEP VYIDLTLSEN KEEPVKLAVV CRDGQVHLFE
     HILNGYCKKP LTSNCTIQIA TPGKGKKSTP KPIPILAAGF CSDKMSLLLV YGSWFQPTIE
     RVALNSREPH MCLVRDISNC WAPKVETAIT KVRTPVMNSE AKVLVPGIPG HHAAIKPAPP
     QTEQVESKRK SGGNEVSIEE RLGAMDIDTH KKGKEDLQTN SFPVLLTQGL ESNDFEMLNK
     VLQTRNVNLI KKTVLRMPLH TIIPLLQELT KRLQGHPNSA VLMVQWLKCV LTVHASYLST
     LPDLVPQLGT LYQLMESRVK TFQKLSHLHG KLILLITQVT ASEKTKGATS PGQKAKLVYE
     EESSEEESDD EIADKDSEDN WDEDEEESES EKDEDVEEED EDAEGKDEEN GEDRDTASEK
     ELNGDSDLDP ENESEEE
//
